Clinical Trials Logo

Advanced B Cell Malignancies clinical trials

View clinical trials related to Advanced B Cell Malignancies.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01957579 Completed - Blood Cancer Clinical Trials

A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies

Start date: May 2011
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the safety and tolerability of MEDI-551 in Japanese patients with relapsed or refractory advanced B-cell malignancies.